Use of autologous platelet-rich fibrin on hard-to-heal wound
P. Steenvoorde, L.P. van Doorn, C. Naves, J. Oskam
Journal of Wound Care 2008; 1 7 (2 ): 60-63
Our experience in the treatment of chronic ulcers using Vivostat® PRF®. Series of 10 cases
M. Fuertes, V. Velasco, G.E. Larrañagag, G. Peirona
Cir. plást. Iberolatinoam 2009; 35 (2): 141-148
Clinical Experience of Vivostat® Platelet Rich Fibrin (PRF®) in treatment of Diabetic foot ulcers
M. Löndahl
Presented at the 13eme Conference nationale des plaies et cicatrisations 2009
Comparative Study of two different treatment methods using autologous thrombocyte-fibrin treatment of diabetic foot ulcers
G. Larsson, M. Löndahl
Presented at Jubileumsriksstämman 2008
Growth factor and proteinase profile of Vivostat platelet-rich fibrin linked to tissue repair
M. S. Agren, K. Rasmussen, B. Pakkenberg & B. Jørgensen
Vox Sanguinis (2013); 107(1), 37-43
Autologes thrombozytenreiches Fibrin – eine neue Möglichkeit zur Wundtherapie bei komplizierten chronischen Wunden
K.P. Arenth, C. Schneider, D. Ockert
Wundtherapie bei komplizierten chronischen Wunden 2009
Selected case stories, Vivostat® platelet rich fibrin (PRF®) in the treatment of chronic wounds
B. Jørgensen, M. Löndahl,G. Larsson, H. Monberg
Published in the Swedish wound magazine “Sår” - March 2008
Vivostat PRF® for the treatment of hard to heal ischemic diabetic ulcer
P. Steenvoorde, L. van Doorn, J. Oskam
From the department of SurgeryRijnland Hospital Leiderdorp and the Rijnland Wound Clinic Leiderdorp, in the Netherlands
Use of autologous growth factors to heal chronic wounds
D. Sommer
Forum Sanitas – The Informative Medical Magazine 2008
Platelet Rich Fibrin (PRF) for hard to heal ulcers in patients with diabetic feet
C. Naves, P. Steenvoorde, L. Van Doorn
European Tissue Repair Society 2008
Autologus Platelet-Rich Fibrin for the treatment of hard to heal diabetic ulcers
L. van Doorn, P. Steenvoorde, J. Oskam
Noordwijkerhout 2007
Platelet Rich Fibrin seems to be a safe and effective treatment in diabetic patients with lower extremity fistula
Å. Asmundsson, M. Löndahl, I. Dupros, G. Larsson, P. Katzman
Skane University Hospital (Lund, SWEDEN)
Effects of locally applied autologous Platelet-Rich Fibrin® (PRF®) on split-thickness skin graft donor sites
P. Danielsen, B. Jørgensen, T. Karlsmark, L.N. Jørgensen, M. Ågren
Presented at EWMA 2010
Platelet gel applications in oral mucositis in CGVHD
A.S. Ferraro et al.
Presented at the European Hematology Association Congress 2008
Application of PLTs gel for the treatment of refractory chronic GvHD skin lesions
A. Picardi et al.
Presented at the meeting European Group for Blood and Marrow Transplantation
Tension free Primary Closure with Autologous Platelet Gel Versus VivostatTM for the Definitive Treatment of Chronic Sacrococcygeal Pilonidal Disease
Gipponi et al
In vivo 24: 583-590 (2010)
Autologes thrombozytenreiches Fibrin kombiniert mit vagaler Stimulation
T. Payrits et. al
Skriptum Kongressjournal, 12. Jahrestagung der Österreichischen gesellschaft für Wundbehandlung
10 April, 2010
Platelet Rich Fibrin seems to be a safe and effective treatment in diabetic patients with lower extremity fistula
M. Løndahl et. al
Platelet gel applications in oral Mucisitis in CGVHD
A.S. Ferraro et. al
13th Congress of the European Hematology Association
June 12-15, 2008
Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes
Bayer et. al
Experimental Dermatology, 2016, 25, 460–465
